Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

Three Months Ended

Year Ended

December 31, 2022

January 1, 2022

December 31, 2022

January 1,
2022

Revenues

$   257,325

$   208,680

$    1,024,106

$   720,860

Cost of revenues

100,028

80,849

381,549

295,468

Gross profit

157,297

127,831

642,557

425,392

Operating expenses:

   Research and development

86,649

71,705

332,326

273,208

   Selling, general and administrative

46,573

53,487

190,971

185,022

Operating expenses

133,222

125,192

523,297

458,230

Operating income (loss)

24,075

2,639

119,260

(32,838)

Other income (expense):

   Interest income and other, net

4,299

2,595

13,915

5,696

   Interest expense

(1,849)

(6,628)

(6,723)

(31,033)

Income (loss) from continuing operations before income taxes

26,525

(1,394)

126,452

(58,175)

Provision for income taxes

1,579

884

38,450

13,427

Equity-method earnings

415

7,791

3,400

13,728

Income (loss) from continuing operations

25,361

5,513

91,402

(57,874)

Income (loss) from discontinued operations, net of income taxes

--

(8,611)

--

2,175,273

Net income (loss)

$   25,361

$   (3,098)

$     91,402

$  2,117,399

Basic earnings (loss) per share:

   Continuing operations

$       0.78

$        0.14

$         2.61

$           (1.35)

   Net income

$       0.78

$       (0.08)

$         2.61

$          49.44

Diluted earnings (loss) per share:

   Continuing operations

$       0.76

$        0.13

$         2.54

$          (1.35)

   Net income

$       0.76

$       (0.08)

$         2.54

$         47.78

Weighted-average common shares outstanding:

   Basic

32,542

38,965

35,086

42,830

   Diluted

33,265

41,031

36,042

44,315